Radiothérapie Moléculaire et Innovation Thérapeutique (RaMo-IT)

Laboratory presentation

The molecular radiotherapy unit focuses its research on the response to ionizing radiation by 5 axes, 1) Cell death, 2) Inflammation and immunological response, 3) Tumor microenvironment and metabolism, 4) Pharmacomodulation and technological innovation, 5) Translational research. The aim of these various research axes is to propose new anti-cancer therapies by improving its detection (prediction factor) and by proposing a better prognosis by making radiotherapy more effective.

The 20 latest publications

Title Authors Publication date Source
HIPEC: The age of reason Philippe Morice 03/01/24 Bulletin du Cancer
Radiotherapy in the management of synchronous metastatic lung cancer Antonin Levy 02/01/24 Cancer/Radiotherapie
Sputum handling for rheology Bruno Degano 12/01/23 Scientific Reports
Benefit of medial retropharyngeal nodal region sparing in nasopharyngeal carcinoma patients: the final answer? Roger Sun 12/01/23 Asia-Pacific Journal of Clinical Oncology
KRAS<sup>G12C</sup> inhibition using MRTX1257: a novel radio-sensitizing partner Nicolas Signolle 12/01/23 Journal of Translational Medicine
Local control strategies for management of NSCLC with oligoprogressive disease Clément Quevrin, Eric Deutsch, Antonin Levy 11/01/23 Cancer Treatment Reviews
In vivo reduction of RAD51-mediated homologous recombination triggers aging but impairs oncogenesis E. Despras, P. L. Kannouche 10/16/23 EMBO Journal
Interactions between vascular endothelium and immune cells: A key control point of radiation-induced digestive lesions Michele Mondini, Eric Deutsch 09/01/23 Cancer/Radiotherapie
Radiation-induced lymphopenia: Lymphocytes as a new organ at risk Pierre Antoine Laurent, Eric Deutsch 09/01/23 Cancer/Radiotherapie
Radiation-induced pulmonary fibrosis: New potential targets Eric Deutsch, Lydia Meziani 09/01/23 Cancer/Radiotherapie
Five-fraction radiotherapy for breast cancer Sofia Rivera 09/01/23 Cancer/Radiotherapie
Breast cancer radiation therapy: Current questions in 2023 Sofia Rivera 09/01/23 Cancer/Radiotherapie
Sulfite derivatives use in french pharmaceutical products in 2022 Daphné Morel, Loïc Verlingue, Eric Deutsch 09/01/23 Journal de Pharmacie Clinique
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study Christophe Massard 08/01/23 The Lancet Oncology
Risk factors for obesity in adulthood among survivors of childhood cancer Ibrahima Diallo 07/01/23 Obesity
Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation Lydia Meziani, Marine Gerbé de Thoré, Céline Clémenson, Winchygn Liu, Pierre Antoine Laurent, Michele Mondini, Eric Deutsch 06/02/23 Journal for ImmunoTherapy of Cancer
Increased abscopal responses after radiation therapy for oligoprogressive patients receiving immune checkpoint inhibitors? Antonin Levy 04/01/23 Translational Cancer Research
CANTO-RT: One of the Largest Prospective Multicenter Cohort of Early Breast Cancer Patients Treated with Radiotherapy including Full DICOM RT Data Sofia Rivera 02/01/23 Cancers
Cytofluorometric characterization of the myeloid compartment of irradiated mouse tumors Marine Gerbé De Thoré, Lydia Meziani, Eric Deutsch, Michele Mondini 01/01/23 Methods in Cell Biology
Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumors Pierre Antoine Laurent, Lydia Meziani, Eric Deutsch 01/01/23 OncoImmunology

Number of publications of the laboratory by scientific field (2016-2021)

Every paper can be classified in one or more scientific fields. The figure below shows the lab's number of publications in each scientific field, according to the ASJC classification (Elsevier)